Sandra M Bell

Dr. Sandra M Bell is a Lecturer at the School of Medicine, University of Leeds, Faculty of Medicine and Health. She is a Group Leader in the Breast Cancer Research Group within the Leeds Institute of Medical Research at St James's and leads the International PhD Academy: Medical Research. Her work bridges cancer biology, genetics, and molecular medicine, with a focus on breast and ovarian cancers.

Her educational background includes a BSc in Biochemistry from the University of Sussex and a PhD in Colon Cancer Genetics from the University of Leeds. She is also a Fellow of the Higher Education Academy.

Dr. Bell's research centers on the functional roles of neurodevelopmental genes MCPH1 and CSMD1 in cancer, particularly their involvement in DNA repair, cell cycle checkpoints, and mitotic regulation. She investigates how disruptions in these genes contribute to tumorigenesis and poor prognosis. Her lab employs high-throughput siRNA screening and synthetic lethality strategies to uncover novel therapeutic targets.

While no publications are currently listed in the provided text, her research direction emphasizes functional genomics, molecular oncology, and precision medicine approaches in solid tumors.

• Fellow of the Higher Education Academy

Dr. Bell actively supervises numerous PhD and MSc students, both as primary supervisor and co-supervisor, and contributes to graduate education as Postgraduate Research Tutor. She teaches in the MBChB program and leads modules in the Molecular Medicine MSc. She has previously mentored a wide range of successful MSc, MRes, and PhD graduates. Her group has included research technicians and postdoctoral researchers, reflecting an active and collaborative research environment.

She is a member of the School Ethics Committee and part of key research institutes including the Breast Cancer Research Group and the International PhD Academy. Her work is conducted within the Leeds Institute of Medical Research at St James's, a hub for translational cancer research.